Hip replacement bleeding breakthrough: drug could cut transfusions
NCT ID NCT06903299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether tranexamic acid, a drug that helps blood clot, can reduce blood loss during planned hip replacement surgery. About 1000 adults having elective hip replacement will receive the drug directly into the joint during surgery. The goal is to see if it lowers the need for blood transfusions and speeds up recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD LOSS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia
Brno, Czechia, 62700, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- Smarter transfusions: tailoring blood use after heart surgery
- Can a common drug make abortion safer? new trial aims to find out
- Blood transfusion trends in trauma: what worked and what Didn't?
- Spine tumor bleeding study halted after just 4 patients
- New oxygen-based test could prevent kidney damage from blood transfusions in ICU